Description:
The Abbott Abon Cotinine 200Sens Device is a rapid, qualitative immunoassay designed to detect cotinine — the primary metabolite of nicotine — in human urine at a cutoff concentration of 200 ng/mL. This test provides a reliable indication of tobacco or nicotine exposure, making it suitable for clinical assessments, smoking cessation programs, insurance screenings, and workplace wellness initiatives. The one-step, dip-and-read format enables fast, instrument-free testing in a variety of settings.
Key Features:
-
Nicotine Exposure Detection: Specifically detects cotinine at a 200 ng/mL cutoff.
-
Rapid Results: Produces accurate, easy-to-read results within 5–10 minutes.
-
High Sensitivity: Enables effective screening of active tobacco or nicotine use.
-
Simple Operation: No specialized equipment required; results are visually interpreted.
-
Compact & Portable: Ideal for use in clinics, workplaces, and field environments.
Reviews
There are no reviews yet.